The 3D screen printing production systems designed to process active pharmaceutical ingredients, biomaterials or other materials are intended to use in Cleanroom Class D/ISO 8 environments and feature GAMP5-compliant software systems. These systems can be customized to further specific GMP criteria upon request.
Exentis’ additive screen-printing technology sets new standards in the processing of active pharmaceutical ingredients and biomaterials. The resource-saving cold printing process enables the production of tablets with different combinations of active ingredients, such as dosage forms with customizable release profiles, in one single, fully automated step.
Thanks to the use of pastes, these systems can be reconfigured to produce different active ingredients within minutes, as there is no contamination with powder dust. The shape of the tablets can be altered immediately by changing the screens, with new screens deliverable within two days.